| Bioactivity | Rimegepant (sulfate hydrate) is an orally active, selective and competitive calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki of 0.027 nM. Rimegepant (sulfate hydrate) can be used in migraine related research[1]. |
| CAS | 1374024-48-2 |
| Formula | C28H32F2N6O3.1/2H2O4S.3/2H2O |
| Molar Mass | 610.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Blair HA. Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine. CNS Drugs. 2023 Mar;37(3):255-265. |
Rimegepant sulfate hydrate
CAS: 1374024-48-2 F: C28H32F2N6O3.1/2H2O4S.3/2H2O W: 610.26
Rimegepant (sulfate hydrate) is an orally active, selective and competitive calcitonin gene-related peptide (CGRP) recep
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.